First identified as an adaptor protein mediating innate immune signaling induced by cytosolic DNA sensors, STING's function as cyclic di-nucleotide sensor has been described only recently (101), generating great enthusiasm for its potential use in cancer immunotherapy [Reviewed in Iurescia et al. (102)]. This evidence concerns the gene STING1 and cancer.